Login to Your Account

Financings Roundup

Friday, June 28, 2013
• Ampliphi BioSciences Corp., of Seattle, completed a private placement of convertible preferred stock for gross proceeds of $7 million to advance bacteriophage products for bacterial infections.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription